AUTOLIV INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data AUTOLIV INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	10,074	10,383	8,678	8,548	7,447	8,230	8,842	10,475	10,390	10,815
Cost of revenue	6,294	6,457	6,967	6,963	6,201	6,719	7,446	8,654	8,463	8,741
Gross profit	1,628	1,680	1,711	1,584	1,247	1,511	1,396	1,822	1,927	2,074
Research and development				406	376	391	390	425	398	413
Selling, general and administrative	394	407	390	399	389	432	440	500	530	571
Operating income	831	860	686	726	382	675	659	690	979	1,088
Interest expense	62.2	61.1	66.1	70	73	60	60	93	108	103
Interest income	4.5	7.4	6.9	4	5	4	6	13	13	10
Other non-operating income	8.3	-15.2	-18	-14	-25	-7	-5	-3	-16	-15
Pre-tax income	784	792	612	648	291	614	603	612	875	986
Income tax	224	204	235	186	103	177	178	123	227	250
Income from continuing operations	558	586	376	462	187
Net income to minority interests	-5.5	-124				2	2	1	1	1
Net income	567	427	190	462	187	435	423	488	646	735
EBITDA	1,214	1,285	1,083	1,077	753	1,069	1,022	1,068	1,366	1,495
EPS, basic	6.43	4.88	2.19	5.29	2.14	4.97	4.86	5.74	8.06	9.59
EPS, diluted	6.42	4.87	2.18	5.29	2.14	4.96	4.85	5.72	8.04	9.55
Shares, basic (weighted)	88.2	87.5	87.1	87.2	87.3	87.5	87.1	85	80.2	76.6
Shares, diluted (weighted)	88.4	87.7	87.3	87.4	87.5	87.7	87.2	85.2	80.4	76.9
Dividend per share	2.32	2.40	2.48	2.48	0.00	1.88	2.58	2.66	2.74	3.12

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	1,227	960	616	445	1,178	969	594	498	330	604
Receivables	1,515	1,697	1,652	1,624	1,820	1,699	1,907	2,198	1,993	2,236
Inventory	609	704	758	741	798	777	969	1,012	921	992
Other current assets	8.7	2.8	1.9	28.4	263	20	29	33	34	57
Total current assets	4,141	4,205	3,285	3,002	4,269	3,675	3,714	3,974	3,483	4,101
Property, plant and equipment	1,658	1,609	1,690	1,816	1,869	1,855	1,960	2,192	2,239	2,417
Lease right-of-use assets				157	141	132	160	176	158	171
Goodwill	1,381	1,397	1,390	1,388	1,398	1,387	1,375	1,378	1,368	1,379
Intangible assets	213	42.6	32.7	22.3	14	8	7	7	7	7
Other non-current assets	54.9	48.8	41.8	386	466	481	502	606	548	568
Total assets	8,234	8,550	6,722	6,771	8,157	7,537	7,717	8,332	7,804	8,644
Accounts payable	1,197	957	978	941	1,227	1,129	1,693	1,978	1,799	2,007
Accrued liabilities	921	830	935	817	1,260	987	915	1,135	1,056	1,050
Short-term debt	219	19.7	621	368	302	346	711	538	387	419
Total current liabilities	2,598	2,655	2,866	2,410	3,147	2,821	3,642	4,035	3,633	3,923
Long-term debt	1,324	1,311	1,609	1,726	2,110	1,662	1,054	1,324	1,522	1,734
Lease liabilities				119	103	94	119	135	118	122
Other non-current liabilities	149	144	152	153	126	115	121	109	92	113
Total liabilities	4,308	4,381	4,825	4,649	5,734	4,889	5,091	5,762	5,519	6,062
Total debt	1,543	1,341	1,609	1,726	2,110	1,662	1,054	1,324	1,522	1,734
Paid-in capital	1,329	1,329	1,329	1,329	1,329	1,329	1,113	1,044	910	850
Retained earnings	3,862	4,079	2,042	2,284	2,471	2,742	2,310	2,289	2,105	2,308
Treasury stock	-1,051	-1,189	-1,167	-1,158	-1,147	-1,133	-379	-368	-160	-146
Other comprehensive income	-566	-288	-423	-449	-347	-408	-522	-496	-659	-518
Shareholders' equity	3,677	4,035	1,884	2,109	2,409	2,633	2,613	2,557	2,276	2,572
Minority interests	249	134	13.1	13.2	14	15	13	13	10	10
Total equity	3,926	4,169	1,897	2,122	2,423	2,648	2,626	2,570	2,285	2,582
Total liabilities and equity	8,234	8,550	6,722	6,771	8,157	7,537	7,717	8,332	7,804	8,644
Shares outstanding	88.2	87	87.1	87.2	87.4	87.5	86.2	82.6	77.7	74.7

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	562	303	184	463	188	437	425	489	648	736
Depreciation and amortization	383	426	397	351	371	394	363	378	387	407
Stock-based compensation	11.1	8.5
Deferred income tax	-24.8	-47.2	3	-16	-24	-20	-40	-109	-30	-13
Change in receivables	-292	-102	-48.4	25	-415	283	-297	-221	47	-98
Change in inventory	-72.6	-21	-124	15	-34	-19	-243	-22	28	-8
Change in payables	271	112	-37.8	36	672	-314	596	255	-83	119
Cash from operations	868	936	591	641	849	754	713	982	1,059	1,157
Capital expenditures	-507	-580	-560	-483	-344	-458	-585	-573	-579	-441
Acquisitions	-226	-13.8
Cash from investing	-726	-697	-628	-476	-340	-454	-485	-569	-563	-423
Debt issued			582	244	1,177	0	0	559	526	521
Debt repaid		-36		0	-723	-295	-357	-533	-306	-311
Stock issued	5.9	7.9	8.2	1	1	3	0	1	1	0
Share buybacks		-157				0	-115	-352	-552	-351
Dividends paid	-203	-209	-214	-217	-54	-165	-224	-225	-219	-238
Cash from financing	-200	-566	-245	-338	160	-469	-531	-490	-680	-369
Exchange rate effect	-49	60.4
Net change in cash	-107	-267	-344	-171	734	-209	-375	-96	-168	274
Free cash flow	362	356	30.6	158	505	296	128	409	480	716
Interest paid	64	64	66	72	73	60	64	80	104	98
Income taxes paid	247	204	214	192	104	207	215	192	207	230

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $117.52 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	19.2%	Gross profit / revenue.
Operating margin	9.2%	Operating income / revenue.
EBITDA margin	13.1%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	8.0%	Pre-tax income / revenue.
Net margin	5.8%	Net income / revenue.
FCF margin	6.8%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	10.5%	Cash from operations / revenue.
Effective tax rate	27.6%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	25.8%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	7.6%	Net income / average total assets.
Return on invested capital (ROIC)	19.4%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	4.1%	Research and development expense / revenue.
SG&A / revenue	5.2%	Selling, general and administrative expense / revenue.
Capex / revenue	3.6%	Capital expenditures / revenue.
D&A / revenue	3.9%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	4.1%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	6.9%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	7.7%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	7.6%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	14.1%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	10.7%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	11.1%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	18.2%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	23.3%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	9.4%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	13.5%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	14.7%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	13.8%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	20.2%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	31.5%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	18.8%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	25.3%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	34.9%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	9.3%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	17.5%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	6.4%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	49.2%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	77.5%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	7.2%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	13.9%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	6.5%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y	13.0%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-0.5%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	1.3%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	10.8%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	3.9%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	1.2%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-4.4%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-4.1%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-2.5%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.03x	Current assets / current liabilities.
Quick ratio	0.10x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.10x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.68x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	19.9%	Total debt / total assets.
Liabilities / assets	70.6%	Total liabilities / total assets.
Net debt	$1.31B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	0.90x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	9.86x	Operating income / interest expense.
Working capital	$112.0M	Current assets - current liabilities.
Tangible book value	$2.49B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.30x	Revenue / average total assets.
Fixed asset turnover	4.73x	Revenue / average property, plant and equipment.
Inventory turnover	9.47x	Cost of revenue / average inventory.
Days inventory	39 days	365 x average inventory / cost of revenue.
Days payables	81 days	365 x average accounts payable / cost of revenue.
FCF conversion	117.9%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	34.8%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$8.65	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$149.31	Revenue / diluted weighted shares.
FCF per share	$10.20	Free cash flow / diluted weighted shares.
Operating cash flow per share	$15.65	Cash from operations / diluted weighted shares.
Book value per share	$33.56	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$33.56	Tangible book value / shares outstanding.
Cash per share	$5.08	(Cash + short-term investments) / shares outstanding.
Payout ratio	40.5%	Dividends paid / net income, when net income is positive.
Dividends / FCF	34.3%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	59.4%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$8.61B	Share price x shares outstanding.
Enterprise value	$9.92B	Market cap + total debt - cash - short-term investments.
P/E	13.4x	Market cap / net income. Only when net income is positive.
P/S	0.78x	Market cap / revenue.
P/B	3.46x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	3.46x	Market cap / tangible book value, when positive.
P/FCF	11.4x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	7.41x	Market cap / cash from operations, when positive.
EV/Sales	0.90x	Enterprise value / revenue.
EV/EBIT	9.76x	Enterprise value / operating income, when both are positive.
EV/EBITDA	6.84x	Enterprise value / EBITDA, when both are positive.
EV/FCF	13.1x	Enterprise value / free cash flow, when both are positive.
FCF yield	8.8%	Free cash flow / market cap.
Earnings yield	7.5%	Net income / market cap (the inverse of P/E).
Dividend yield	3.0%	Dividends paid over the period / market cap.
Shareholder yield	8.2%	(Dividends paid + share buybacks) / market cap.
PEG	0.53x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was AUTOLIV INC's revenue in fiscal 2025?

AUTOLIV INC reported revenue of $10.82B for fiscal 2025, 4.1% higher than the year before.

Was AUTOLIV INC profitable in fiscal 2025?

Yes. Net income was $735.0M, a net margin of 6.8%.

How much free cash flow did AUTOLIV INC generate in fiscal 2025?

Cash from operations of $1.16B minus capital expenditures of $441.0M left free cash flow of $716.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to AUTOLIV INC